Home › Stock analysis › CRVS
Corvus Pharmaceuticals (CRVS) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
What changed since yesterday
- Closed at $9.65, +1.37% vs the prior close of $9.52.
- Volume 820.07K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CRVS rises 1.4% to $9.65. Closed at $9.65, +1.37% vs the prior close of $9.52. Day range $9.50–$10.00, opened at $9.73.
Last close$9.65+1.37%
Day range9.50–10.00
Open9.73
Volume820.07K
52-week range6.39–26.95
Avg volume (20d)1.11M
CRVS daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — CRVS rises 1.4% to $9.65
- Closed at $9.65, +1.37% vs the prior close of $9.52. Day range $9.50–$10.00, opened at $9.73.
- Volume was 820.07K shares, 0.8x its 50-day average of 1.04M.
- Price is -24.2% vs its 50-day average ($12.74) and -32.5% vs its 200-day average ($14.29).
- 52-week range $6.39–$26.95; today's close sits at 16% of that range, 64.2% below the 52-week high.
Oct 16, 2026 — CRVS slides 3.4% to $9.52
- Closed at $9.52, -3.35% vs the prior close of $9.85. Day range $9.43–$9.81, opened at $9.81.
- Volume was 1.04M shares, 1.0x its 50-day average of 1.03M.
- Price is -25.8% vs its 50-day average ($12.82) and -33.3% vs its 200-day average ($14.28).
- 52-week range $6.39–$26.95; today's close sits at 15% of that range, 64.7% below the 52-week high.
Oct 15, 2026 — CRVS jumps 5.0% to $9.85
- Closed at $9.85, +5.01% vs the prior close of $9.38. Day range $9.36–$10.07, opened at $9.49.
- Volume was 1.00M shares, 1.0x its 50-day average of 1.02M.
- Price is -23.7% vs its 50-day average ($12.91) and -31.0% vs its 200-day average ($14.27).
- 52-week range $6.39–$26.95; today's close sits at 17% of that range, 63.5% below the 52-week high.
Oct 14, 2026 — CRVS dips 0.3% to $9.38, a 6-month low, 3 down days in a row
- Closed at $9.38, -0.32% vs the prior close of $9.41. Day range $9.21–$9.50, opened at $9.31.
- Volume was 976.80K shares, 1.0x its 50-day average of 1.02M.
- Price is -27.8% vs its 50-day average ($12.99) and -34.2% vs its 200-day average ($14.25).
- 52-week range $6.39–$26.95; today's close sits at 15% of that range, 65.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CRVS slides 6.4% to $9.41, a 6-month low
- Closed at $9.41, -6.37% vs the prior close of $10.05. Day range $9.32–$10.03, opened at $9.99.
- Volume was 1.69M shares, 1.7x its 50-day average of 998.63K.
- Price is -28.1% vs its 50-day average ($13.08) and -33.9% vs its 200-day average ($14.25).
- 52-week range $6.39–$26.95; today's close sits at 15% of that range, 65.1% below the 52-week high.
Oct 12, 2026 — CRVS slides 4.5% to $10.05, a 6-month low
- Closed at $10.05, -4.47% vs the prior close of $10.52. Day range $10.02–$10.52, opened at $10.43.
- Volume was 719.70K shares, 0.7x its 50-day average of 999.75K.
- Price is -23.6% vs its 50-day average ($13.16) and -29.4% vs its 200-day average ($14.24).
- 52-week range $6.39–$26.95; today's close sits at 18% of that range, 62.7% below the 52-week high.
Oct 9, 2026 — CRVS jumps 3.0% to $10.52
- Closed at $10.52, +3.04% vs the prior close of $10.21. Day range $10.08–$10.71, opened at $10.21.
- Volume was 1.03M shares, 1.0x its 50-day average of 998.37K.
- Price is -20.5% vs its 50-day average ($13.23) and -26.0% vs its 200-day average ($14.22).
- 52-week range $6.39–$26.95; today's close sits at 20% of that range, 61.0% below the 52-week high.
Oct 8, 2026 — CRVS dips 1.9% to $10.21, a 6-month low on 1.9x normal volume
- Closed at $10.21, -1.92% vs the prior close of $10.41. Day range $9.82–$10.31, opened at $10.15.
- Volume was 1.88M shares, 1.9x its 50-day average of 973.68K — unusually heavy trading.
- Price is -23.1% vs its 50-day average ($13.28) and -28.1% vs its 200-day average ($14.21).
- 52-week range $6.39–$26.95; today's close sits at 19% of that range, 62.1% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — CRVS dips 1.4% to $10.41, a 6-month low, 7 down days in a row
- Closed at $10.41, -1.42% vs the prior close of $10.56. Day range $10.25–$10.65, opened at $10.25.
- Volume was 1.16M shares, 1.2x its 50-day average of 967.29K.
- Price is -21.9% vs its 50-day average ($13.34) and -26.7% vs its 200-day average ($14.20).
- 52-week range $6.39–$26.95; today's close sits at 20% of that range, 61.4% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — CRVS dips 1.7% to $10.56, a 6-month low, 6 down days in a row
- Closed at $10.56, -1.68% vs the prior close of $10.74. Day range $10.20–$10.96, opened at $10.75.
- Volume was 1.44M shares, 1.5x its 50-day average of 955.36K.
- Price is -21.2% vs its 50-day average ($13.39) and -25.5% vs its 200-day average ($14.18).
- 52-week range $6.39–$26.95; today's close sits at 20% of that range, 60.8% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — CRVS dips 1.5% to $10.74, a 6-month low, 5 down days in a row
- Closed at $10.74, -1.47% vs the prior close of $10.90. Day range $10.45–$11.15, opened at $10.88.
- Volume was 823.70K shares, 0.9x its 50-day average of 958.01K.
- Price is -20.1% vs its 50-day average ($13.44) and -24.2% vs its 200-day average ($14.17).
- 52-week range $6.39–$26.95; today's close sits at 21% of that range, 60.1% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — CRVS ends flat (-0.3%) to $10.90, a 6-month low, 4 down days in a row
- Closed at $10.90, -0.27% vs the prior close of $10.93. Day range $10.64–$11.11, opened at $11.11.
- Volume was 1.35M shares, 1.4x its 50-day average of 951.04K.
- Price is -19.2% vs its 50-day average ($13.49) and -23.0% vs its 200-day average ($14.15).
- 52-week range $6.39–$26.95; today's close sits at 22% of that range, 59.6% below the 52-week high.
- That makes 4 straight losses.
CRVS bull case vs bear case (from the data)
Bull case
- Insiders made 12 open-market purchases in the last 12 months.
Bear case
- Price is -24.2% vs its 50-day average — short-term trend is down.
- Price is -32.5% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $15.28M.
- Share count up 12.9% in a year (dilution).
- High volatility: average daily move of 3.2% over 20 sessions.
CRVS latest news & SEC filings
Every SEC filing by or about CRVS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$17.96M (prior year -$8.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.19 (prior year -$0.10) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade CRVS
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.16% (largest 8.2%). That is a volatile stock.
- Liquidity: about 1.11M shares (≈$10.71M) trade per day on average.
- 52-week position: $9.65 vs a range of $6.39–$26.95 (16% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: David Scott Moore bought 21,700 shares on Jun 11, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jul 22, 2026.
- Share count: 84.12M shares outstanding (Aug 6, 2026), +12.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CRVS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 9.73 | 10.00 | 9.50 | 9.65 | 820.07K |
| Oct 16, 2026 | 9.81 | 10.11 | 9.43 | 9.52 | 1.04M |
| Oct 15, 2026 | 9.49 | 10.07 | 9.36 | 9.85 | 1.00M |
| Oct 14, 2026 | 9.31 | 9.50 | 9.21 | 9.38 | 976.80K |
| Oct 13, 2026 | 9.99 | 10.03 | 9.32 | 9.41 | 1.69M |
| Oct 12, 2026 | 10.43 | 10.52 | 10.02 | 10.05 | 719.70K |
| Oct 9, 2026 | 10.21 | 10.71 | 10.08 | 10.52 | 1.03M |
| Oct 8, 2026 | 10.15 | 10.31 | 9.82 | 10.21 | 1.88M |
| Oct 7, 2026 | 10.25 | 10.65 | 10.25 | 10.41 | 1.16M |
| Oct 6, 2026 | 10.75 | 10.96 | 10.20 | 10.56 | 1.44M |
| Oct 5, 2026 | 10.88 | 11.15 | 10.45 | 10.74 | 823.70K |
| Oct 2, 2026 | 11.11 | 11.11 | 10.64 | 10.90 | 1.35M |
| Oct 1, 2026 | 11.56 | 11.75 | 10.89 | 10.93 | 1.31M |
| Sep 30, 2026 | 11.99 | 12.03 | 11.50 | 11.52 | 875.70K |
| Sep 29, 2026 | 12.36 | 12.42 | 11.72 | 11.76 | 881.90K |
| Sep 28, 2026 | 11.66 | 12.12 | 11.25 | 11.87 | 1.21M |
| Sep 25, 2026 | 11.92 | 12.04 | 11.41 | 11.62 | 1.10M |
| Sep 24, 2026 | 12.46 | 12.48 | 11.51 | 11.80 | 1.14M |
| Sep 23, 2026 | 13.30 | 13.45 | 12.24 | 12.54 | 945.20K |
| Sep 22, 2026 | 12.55 | 13.46 | 12.35 | 13.44 | 805.30K |
About Corvus Pharmaceuticals
Corvus Pharmaceuticals (CRVS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1626971.
CRVS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ian T Clark | Director | Jun 15, 2026 |
| Andrew C. Chan | Director | Apr 27, 2026 |
| Linda Grais | Director | Jun 15, 2026 |
| Richard A Md Miller | President and CEO | May 20, 2026 |
| David Scott Moore | Director | Jun 15, 2026 |
| Peter A. Thompson | Director | Jun 15, 2026 |
| Den Broek Richard Van | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeffrey Arcara | Chief Business Officer | Dec 8, 2025 |
| William Benton Jones | See Remarks | Dec 8, 2025 |
| Leiv Lea | Chief Financial Officer | Dec 8, 2025 |
| Richard A Md Miller | President and CEO | May 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | David Scott Moore | Buy | 21,700 | $11.53 |
| Jun 11, 2026 | David Scott Moore | Buy | 21,700 | $11.53 |
| Jun 11, 2026 | David Scott Moore | Buy | 21,700 | $11.53 |
| Jun 11, 2026 | David Scott Moore | Buy | 21,700 | $11.53 |
| May 18, 2026 | Richard A Md Miller | Buy | 5,000 | $12.05 |
| May 18, 2026 | Richard A Md Miller | Buy | 1,932 | $12.01 |
| May 18, 2026 | Richard A Md Miller | Buy | 5,000 | $12.05 |
| May 18, 2026 | Richard A Md Miller | Buy | 1,932 | $12.01 |
| May 18, 2026 | Richard A Md Miller | Buy | 5,000 | $12.05 |
| May 18, 2026 | Richard A Md Miller | Buy | 1,932 | $12.01 |
| May 18, 2026 | Richard A Md Miller | Buy | 5,000 | $12.05 |
| May 18, 2026 | Richard A Md Miller | Buy | 1,932 | $12.01 |
CRVS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-15.28M | -0.53 | $-32.80M |
| Dec 31, 2024 | — | $-62.29M | -1.02 | $-25.42M |
| Dec 31, 2023 | — | $-27.03M | -0.56 | $-23.93M |
| Dec 31, 2022 | — | $-41.31M | -0.89 | $-27.02M |
| Dec 31, 2021 | — | $-43.24M | -1.03 | $-36.72M |
Latest balance sheet: total assets $239.27M, total liabilities $13.95M, cash $18.91M (as of Jun 30, 2026).
CRVS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $13.86 |
| May 7, 2026 | 8-K Item 2.02 (results) | $14.59 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $16.01 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $7.64 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $4.13 |
| May 8, 2025 | 8-K Item 2.02 (results) | $3.35 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $3.93 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $8.69 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Mar 19, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on CRVS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.